Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Other Non-Current Assets (2022 - 2025)

Gossamer Bio (GOSS) has 4 years of Other Non-Current Assets data on record, last reported at $407000.0 in Q3 2025.

  • For Q3 2025, Other Non-Current Assets rose 43.82% year-over-year to $407000.0; the TTM value through Sep 2025 reached $407000.0, up 43.82%, while the annual FY2024 figure was $283000.0, 54.21% down from the prior year.
  • Other Non-Current Assets reached $407000.0 in Q3 2025 per GOSS's latest filing, up from $383000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $1.3 million in Q2 2022 and bottomed at $59000.0 in Q2 2024.
  • Average Other Non-Current Assets over 4 years is $580000.0, with a median of $618000.0 recorded in 2023.
  • Peak YoY movement for Other Non-Current Assets: crashed 92.34% in 2024, then surged 549.15% in 2025.
  • A 4-year view of Other Non-Current Assets shows it stood at $680000.0 in 2022, then dropped by 9.12% to $618000.0 in 2023, then plummeted by 54.21% to $283000.0 in 2024, then skyrocketed by 43.82% to $407000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Assets were $407000.0 in Q3 2025, $383000.0 in Q2 2025, and $310000.0 in Q1 2025.